论文部分内容阅读
目的探讨彩超在射频消融联合无水酒精注射治疗肝癌(PLC)的临床应用价值。方法对我院30例肝癌患者在超声引导下实施射频消融联合无水酒精注射治疗措施,评价治疗效果及彩超应用价值。结果所有患者在彩超引导下均顺利完成射频消融联合无水酒精治疗措施。彩超复查显示治疗后第3个月瘤周及瘤内血流信号完全消失者22例,瘤周及瘤内血流信号明显减少者6例,肿瘤血供无变化者2例。治疗后第3个月复查彩超显示病灶体积缩小25%以上者28例,病灶无明显缩小或较治疗前略有所增大者2例。结论彩超在射频消融联合无水酒精注射治疗肝癌的临床应用价值巨大,值得应用。
Objective To investigate the clinical value of radiofrequency ablation combined with anhydrous alcohol injection in the treatment of liver cancer (PLC). Methods Thirty patients with liver cancer in our hospital underwent ultrasound-guided radiofrequency ablation combined with anhydrous alcohol injection treatment measures to evaluate the therapeutic effect and the value of color Doppler ultrasound. Results All patients underwent radiofrequency ablation combined with anhydrous alcohol under the guidance of ultrasound. The color Doppler ultrasound examination showed that in the third month after treatment, the tumor and tumor blood flow signals completely disappeared in 22 cases, the tumor and tumor blood flow signals were significantly reduced in 6 cases, the tumor blood supply unchanged in 2 cases. The third month after treatment, color Doppler ultrasound showed that the lesion size reduced by 25% or more in 28 cases, no obvious lesion lesion or slight increase than before treatment in 2 cases. Conclusion The clinical application of radiofrequency ablation combined with anhydrous alcohol injection in the treatment of liver cancer is of great value and should be applied.